Innoviva Inc is a company with a portfolio of royalty healthcare assets... Show more
a biopharmaceutical company
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EVIM | 51.37 | 0.17 | +0.34% |
| Eaton Vance Intermediate Muncpl Inc ETF | |||
| VCEB | 60.53 | -0.06 | -0.10% |
| Vanguard ESG US Corporate Bond ETF | |||
| TVE | 23.32 | -0.04 | -0.17% |
| Tennessee Valley Authority Power Bonds 1999 Series A due May 1 2029 | |||
| CEGX | 14.70 | -0.15 | -1.01% |
| Tradr 2X Long CEG Daily ETF | |||
| SRTY | 24.20 | -0.25 | -1.02% |
| ProShares UltraPro Short Russell2000 | |||
A.I.dvisor indicates that over the last year, INVA has been loosely correlated with DTIL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then DTIL could also see price increases.
| Ticker / NAME | Correlation To INVA | 1D Price Change % | ||
|---|---|---|---|---|
| INVA | 100% | -2.41% | ||
| DTIL - INVA | 34% Loosely correlated | -0.14% | ||
| ATRA - INVA | 31% Poorly correlated | -0.20% | ||
| KNSA - INVA | 31% Poorly correlated | -2.60% | ||
| MCRB - INVA | 31% Poorly correlated | -3.41% | ||
| AKBA - INVA | 29% Poorly correlated | -0.78% | ||
More | ||||
INVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 33 cases where INVA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for INVA just turned positive on August 13, 2026. Looking at past instances where INVA's MACD turned positive, the stock continued to rise in 24 of 44 cases over the following month. The odds of a continued upward trend are 55%.
Following a +2.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVA advanced for three days, in 192 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 56 cases where INVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVA as a result. In 49 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
The 50-day moving average for INVA moved below the 200-day moving average on August 24, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for INVA entered a downward trend on August 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.210) is normal, around the industry mean (20.119). P/E Ratio (4.794) is within average values for comparable stocks, (27.503). Projected Growth (PEG Ratio) (0.249) is also within normal values, averaging (2.525). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (3.984) is also within normal values, averaging (442.180).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. INVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.